Despite these challenges, this review provides suggestions for the establishment of a more transparent, credible, and evidence-based decision-making process in the Hong Kong Hospital Authority Drug Formulary. Proposals for improvement in the listing of new drugs in the formulary should be a priority ...
Insofar as moral hazard has been a problem in Hong Kong, it has largely been limited to drug prescriptions in ambulatory care. In contrast, provision of unnecessary care and drugs is a well-documented problem in both China and Taiwan. Taiwan has made important strides in addressing this ...
Technology Assessment (HTA) policies in overseas countries.METHODS:Details of the decision-making processes including new drug listing submissions, the DAC meeting, procedures before and after the meeting, were extracted from the official Hong Kong Hospital Authority drug formulary management website and...